Alpha DNA Investment Management LLC Sells 262 Shares of Itron, Inc. (NASDAQ:ITRI)

Alpha DNA Investment Management LLC lessened its position in shares of Itron, Inc. (NASDAQ:ITRIFree Report) by 5.4% in the third quarter, HoldingsChannel reports. The fund owned 4,602 shares of the scientific and technical instruments company’s stock after selling 262 shares during the period. Alpha DNA Investment Management LLC’s holdings in Itron were worth $492,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Silvercrest Asset Management Group LLC bought a new stake in shares of Itron in the first quarter valued at approximately $401,000. Handelsbanken Fonder AB boosted its stake in shares of Itron by 62.7% in the third quarter. Handelsbanken Fonder AB now owns 899,789 shares of the scientific and technical instruments company’s stock valued at $96,106,000 after buying an additional 346,615 shares during the period. Select Equity Group L.P. boosted its stake in shares of Itron by 86.2% in the second quarter. Select Equity Group L.P. now owns 603,877 shares of the scientific and technical instruments company’s stock valued at $59,760,000 after buying an additional 279,629 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Itron by 90.7% in the third quarter. Assenagon Asset Management S.A. now owns 511,734 shares of the scientific and technical instruments company’s stock valued at $54,658,000 after buying an additional 243,355 shares during the period. Finally, Hood River Capital Management LLC bought a new stake in shares of Itron in the second quarter valued at approximately $22,612,000. Institutional investors own 96.19% of the company’s stock.

Itron Stock Up 2.2 %

Shares of NASDAQ:ITRI opened at $118.93 on Monday. The company has a fifty day moving average of $109.53 and a 200-day moving average of $104.97. The company has a market capitalization of $5.36 billion, a PE ratio of 24.37, a price-to-earnings-growth ratio of 0.89 and a beta of 1.46. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36. Itron, Inc. has a 52-week low of $65.42 and a 52-week high of $124.90.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings data on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.71. Itron had a net margin of 9.37% and a return on equity of 19.03%. The company had revenue of $615.46 million for the quarter, compared to analysts’ expectations of $596.41 million. During the same quarter in the previous year, the firm posted $0.98 earnings per share. Itron’s revenue for the quarter was up 9.8% on a year-over-year basis. On average, equities analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Robert W. Baird boosted their price target on Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Stephens restated an “equal weight” rating and set a $110.00 price objective on shares of Itron in a research report on Monday, August 5th. Guggenheim boosted their price objective on shares of Itron from $128.00 to $135.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Roth Mkm boosted their price objective on shares of Itron from $125.00 to $130.00 and gave the company a “buy” rating in a research report on Friday, November 1st. Finally, TD Cowen boosted their price objective on shares of Itron from $125.00 to $136.00 and gave the company a “buy” rating in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $123.92.

Get Our Latest Stock Report on ITRI

Insider Buying and Selling

In related news, CEO Thomas Deitrich sold 37,500 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $104.83, for a total value of $3,931,125.00. Following the sale, the chief executive officer now owns 205,276 shares of the company’s stock, valued at $21,519,083.08. The trade was a 15.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.45% of the stock is currently owned by insiders.

Itron Profile

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRIFree Report).

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.